1800
Well-Known Member
"The objective of this study was to explore the pharmacokinetics, safety, tolerability, efficacy, and ease of use of a novel portable thermal-metered-dose inhaler (tMDI) for cannabis in a cohort of eight patients suffering from chronic neuropathic pain and on a stable analgesic regimen including medicinal cannabis. In a single-dose, open-label study, patients inhaled a single 15.1 ± 0.1 mg dose of cannabis using the Syqe Inhaler device
http://informahealthcare.com/doi/abs/10.3109/15360288.2014.941130
http://www.scribd.com/doc/237387644/eisenberg2014a-pdf
http://informahealthcare.com/doi/abs/10.3109/15360288.2014.941130
http://www.scribd.com/doc/237387644/eisenberg2014a-pdf